Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina
Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina
傑柏思方案公司表示，它被富士製藥株式會社所選，以支持在北卡羅來納州霍利斯普林斯的一家端到端的大規模細胞培養合同製造基地的12億美元擴建。
Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina
Jacobs Solutions表示，它被富士膠片Diosynth Biotechnologies選中，以支持北卡羅來納州霍利斯普林斯的端到端大規模細胞培養合同製造基地的12億美元擴建項目